Hybrid08 June 2022

GCOM Congress - Octapharma Symposium

IVIG in dermatomyositis: exploring the evidence for efficacy and safety

Share this page
icon
icon
icon
Wednseday, 8 June 2022
13:40 - 14:25 CEST

Dear participant,

Thank you very much for attending the Octapharma Symposium at the GCOM 2022 congress.

We are delighted to share with you the slides that were presented during the session.

With best regards,

The Faculty

Interested in the presentations?

Prof. Rohit Aggarwal - Unmet needs and IVIG as emerging therapy
Prof. Jiří Vencovský - Personal experience with two anti-NXP-2 positive patients in the ProDERM Study
Prof. Victoria Werth - The importance of measuring skin disease in dermatomyositis